Clinical Trial Update: Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

View source ↗

Summary

This document reports an international, completed study evaluating quality of life in irritable bowel syndrome patients after eight weeks of treatment with mebe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Mebeverine (mebeverine)
• Pinaverium Bromide (pinaverium bromide)

Snippet

Sponsor: Abbott | Conditions: Irritable Bowel Syndrome | Status: COMPLETED